Government of Saskatchewan ministries, Crown corporations and organizations are implementing contingency plans to minimize the impacts of postal service disruption.
Les ministères, sociétés d’État et organismes du gouvernement de la Saskatchewan mettent en œuvre des plans d’urgence (en anglais) visant à réduire les répercussions de l’interruption du service des postes.
Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Released on November 20, 2024
More patients in Saskatchewan living with cystic fibrosis (CF) are now eligible for Trikafta, a medication that improves lung function.
Effective November 15, coverage of Trikafta has expanded to include CF patients who have one of 152 rare genetic mutations which have proven to be responsive to the medication. The expansion will cover most Saskatchewan patients with CF.
"We are pleased to expand coverage for this treatment for more Saskatchewan people with cystic fibrosis," Health Minister Jeremy Cockrill said. "We know that Trikafta improves the quality of life for patients, so expanding coverage to include these rare genetic mutations means more CF patients and their families will benefit for years to come."
On November 4, the Canadian Agency for Drugs and Technologies in Health issued a recommendation that jurisdictions expand coverage of Trikafta for patients with 152 rare genetic mutations.
In Saskatchewan, coverage of Trikafta for CF patients with the most common gene mutation was first introduced in 2021, and coverage was expanded for ages two to five in January 2024. Approximately 95 people in Saskatchewan already benefit from Trikafta coverage. An estimated 25 more are expected to become eligible with this recent criteria expansion to include the 152 rare mutations.
Patients with CF or parents/guardians of children with CF who think they may benefit from therapy with Trikafta are encouraged to speak with their physician.
According to the Canadian Cystic Fibrosis Registry, there are more than 4,400 CF patients in Canada and more than 130 patients in Saskatchewan.
-30-
For more information, contact:We need your feedback to improve saskatchewan.ca. Help us improve
